ADC histograms predict response to anti-angiogenic therapy in patients with recurrent high-grade glioma
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
ADC histograms predict response to anti-angiogenic therapy in patients with recurrent high-grade glioma
Authors
Keywords
-
Journal
NEURORADIOLOGY
Volume 53, Issue 4, Pages 291-302
Publisher
Springer Nature
Online
2010-12-01
DOI
10.1007/s00234-010-0808-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Diffusion-Weighted Magnetic Resonance Imaging as a Cancer Biomarker: Consensus and Recommendations
- (2015) Anwar R. Padhani et al. NEOPLASIA
- Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice
- (2011) J. F. de Groot et al. NEURO-ONCOLOGY
- Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
- (2010) Patrick Y. Wen et al. JOURNAL OF CLINICAL ONCOLOGY
- Predicting and monitoring cancer treatment response with diffusion-weighted MRI
- (2010) Harriet C. Thoeny et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Repeatability of quantitative parameters derived from diffusion tensor imaging in patients with glioblastoma multiforme
- (2009) Michael J. Paldino et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Imaging response criteria for recurrent gliomas treated with bevacizumab: Role of diffusion weighted imaging as an imaging biomarker
- (2009) Rajan Jain et al. JOURNAL OF NEURO-ONCOLOGY
- Recurrent Glioblastoma Multiforme: ADC Histogram Analysis Predicts Response to Bevacizumab Treatment
- (2009) Whitney B. Pope et al. RADIOLOGY
- Prognostic versus predictive value of biomarkers in oncology
- (2008) C.N.A.M. Oldenhuis et al. EUROPEAN JOURNAL OF CANCER
- Contribution of the apparent diffusion coefficient in perilesional edema for the assessment of brain tumors
- (2008) R. Guzman et al. JOURNAL OF NEURORADIOLOGY
- Expensive Cancer Drugs With Modest Benefit Ignite Debate Over Solutions
- (2008) G. Sinha JNCI-Journal of the National Cancer Institute
- Progression-free survival: An important end point in evaluating therapy for recurrent high-grade gliomas
- (2008) Kathleen R. Lamborn et al. NEURO-ONCOLOGY
- Bevacizumab for recurrent malignant gliomas: Efficacy, toxicity, and patterns of recurrence
- (2008) A. D. Norden et al. NEUROLOGY
- K-rasMutations and Benefit from Cetuximab in Advanced Colorectal Cancer
- (2008) Christos S. Karapetis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Relation between cancer cellularity and apparent diffusion coefficient values using diffusion-weighted magnetic resonance imaging in breast cancer
- (2008) Miho I. Yoshikawa et al.
- Malignant renal neoplasms: correlation between ADC values and cellularity in diffusion weighted magnetic resonance imaging at 3 T
- (2008) G. Manenti et al. Radiologia Medica
- Advances in Evaluation of Primary Brain Tumors
- (2008) Wei Chen et al. SEMINARS IN NUCLEAR MEDICINE
- Response criteria for glioma
- (2008) A Gregory Sorensen et al. Nature clinical practice. Oncology
- Technology Insight: water diffusion MRI—a potential new biomarker of response to cancer therapy
- (2008) Daniel M Patterson et al. Nature clinical practice. Oncology
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now